Overview
HydRegen, an Oxford, UK-based biotechnology company developing a biocatalytic platform, raised $8M (£6M) in the first close of its Series A funding. The round was led by Genoa Ventures, with participation from Clean Growth Fund, First Imagine! Ventures, Oxford Technology Management, Headington Holdings, Oxonian, Foxglove Capital, and Rapid Innovation Group....See more
Website
https://hydregenoxford.com/Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$8.0M • Series A
Announced on 10/14/2026
USD8M (GBP6M) first close of Series A.
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.